Fu Zhifeng

President and General Manager

Therapeutic Areas

Drug	Indication	Phase
Human Fibrinogen	Bleeding in fibrinogen deficiency	Phase III
Human Prothrombin Complex Concentrate (PCC)	Anticoagulant reversal, coagulation factor deficiencies	Phase III
Pandemic Influenza Vaccine (Cell Culture-Based)	Pandemic influenza prophylaxis	Phase II
High-Concentration / Subcutaneous Immunoglobulin	Immunodeficiency, CIDP	Research